India's Largest Database on New Projects
Claris gets nod for for Propofol
1 June 2011: Claris Lifesciences (Claris) has received an in-principle approval for its drug Propofol in the European Union (EU) which will allow the company to process the registration across 25 countries.
Propofol, a flagship product of Claris is an anaesthetic product which is widely replacing other anaesthetic drugs as recovery from Propofol is more rapid and clear when compared to other anaesthetic drugs. The molecule involves a complex manufacturing technology and has few competitors worldwide.
The in-principle approval for Propofol will allow the company to process the registration across 25 countries in the EU. This registration will benefit Claris as EU is a lucrative market both in terms of revenue and margins.
Source: Hindu Business Line